Acadian Asset Management’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.4M | Sell |
|
|||||
|
2025
Q1 | $17.9M | Buy |
|
|||||
|
2024
Q4 | $13.4M | Buy |
|
|||||
|
2024
Q3 | $601K | Sell |
|
|||||
|
2024
Q2 | $796K | Sell |
|
|||||
|
2024
Q1 | $6.59M | Sell |
|
|||||
|
2023
Q4 | $8.61M | Sell |
|
|||||
|
2023
Q3 | $12.7M | Sell |
|
|||||
|
2023
Q2 | $46.6M | Sell |
|
|||||
|
2023
Q1 | $119M | Sell |
|
|||||
|
2022
Q4 | $140M | Sell |
|
|||||
|
2022
Q3 | $164M | Sell |
|
|||||
|
2022
Q2 | $199M | Sell |
|
|||||
|
2022
Q1 | $234M | Buy |
|
|||||
|
2021
Q4 | $311M | Sell |
|
|||||
|
2021
Q3 | $315M | Buy |
|
|||||
|
2021
Q2 | $249M | Buy |
|
|||||
|
2021
Q1 | $165M | Buy |
|
|||||
|
2020
Q4 | $142M | Buy |
|
|||||
|
2020
Q3 | $125M | Sell |
|
|||||
|
2020
Q2 | $120M | Buy |
|
|||||
|
2019
Q4 | – | Sell |
|
|||||
|
2019
Q3 | $123M | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $157M | Sell |
|
|||||
|
2018
Q4 | $144M | Sell |
|
|||||
|
2018
Q3 | $220M | Sell |
|
|||||
|
2018
Q2 | $216M | Sell |
|
|||||
|
2018
Q1 | $201M | Sell |
|
|||||
|
2017
Q4 | $199M | Sell |
|
|||||
|
2017
Q3 | $198M | Sell |
|
|||||
|
2017
Q2 | $202M | Sell |
|
|||||
|
2017
Q1 | $178M | Sell |
|
|||||
|
2016
Q4 | $169M | Sell |
|
|||||
|
2016
Q3 | $153M | Sell |
|
|||||
|
2016
Q2 | $135M | Buy |
|
|||||
|
2016
Q1 | $128M | Buy |
|
|||||
|
2015
Q4 | $129M | Buy |
|
|||||
|
2015
Q3 | $113M | Buy |
|
|||||
|
2015
Q2 | $88.4M | Buy |
|
|||||
|
2015
Q1 | $23.8M | Buy |
|
|||||
|
2014
Q4 | $14.2M | Buy |
|
|||||
|
2014
Q3 | $8.53M | Buy |
|
|||||
|
2014
Q2 | $2.03M | Buy |
|